Good evening, everyone. Welcome to the Stocktwits Top 25 newsletter for Week 30 in 2021.
The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD). Our goal is to track the winners and losers over time.
Here are your Stocktwits Top 25 lists for Week 30:
S&P 500
ST Top 25 S&P 500
The ST Top 25 S&P 500 list continued higher for the second straight week.
19 of 25 names closed positive.
The list included select sources of strength. $NUE increased 10.27%, $CBRE climbed 9.95%, and $RHI ripped 5.75%.
Nucor Corp and Fortinet Inc swapped spots. $NUE is now ranked #2. $FTNT is now #3.
One Freshman debuted on the list. The ticker is $CBRE.
The Stocktwits Top 25 S&P 500 Momentum Meter added 1.68% and the S&P 500 dropped 0.37%. The 2.05% differential in favor of the top stocks shows the leading stocks outperformed by a decent amount.
Sponsored
Easy, Cost-Effective Access to ALGO
The Osprey Algorand Trust offers accredited crypto investors an easy, cost-effective way to access Algorand ($ALGO.X), the robust network for security, scalability, & complete transaction finality.
Created by MIT professor and tech pioneer Silvio Micali, Algorand will foster Web 3.0 & revolutionize blockchain technologies.
Nasdaq-100
ST Top 25 Nasdaq 100
The ST Top 25 N100 narrowly finished the week in the green.
13 names closed positive. All 25 names closed green last week.
Dexcom ascended 11.9% and was the list’s biggest gainer. $DXCM is the Top Dawg below.
$ALGN reported record revenue and closed the week at all-time highs. The Freshman is ranked 17th.
Three Freshmen made the list. The companies are Align Technology, Paychex, and Intuitive Surgical.
The ST Top 25 Nasdaq 100 Momentum Meter increased 0.66% in Week 30 while the full Nasdaq 100 fell 1.01%. The 1.67% difference proves the top stocks were stronger than the full index by a fair margin.
Russell 2000
ST Top 25 Russell 2000
The ST Top 25 R2K List was the only one to close negative this week.
16 of 25 names traded lower.
Cassava Sciences sank 43.65% and forfeited the top spot on the list. It’s a Sinner below.
$PAVM rose 15.85%, $HOV hopped 10.2%, and $BTU gained 7.14%.
$PAVM was the list’s only Freshman.
The ST Top 25 R2K Momentum Meter tumbled 3.68% and the Russell 2000 index rallied 0.75%. The 4.43% differential suggests top stocks were weaker than the full index by a large amount.
ST Top 25 TOP DAWG OF THE WEEK 🐶
The ST Top 25 Top Dawg for Week 30 is #6 N100 – DexCom, Inc.
DexCom ripped 11.89% in Week 30 and improved thirteen spots to #6 on the ST Top 25 N100 List.
The medical device company spiked 13% on Friday after reporting better than expected earnings. Here are the stats:
EPS: $0.76 vs $0.43 est
REV: $595M, +32% YoY
$DXCM is up 39.4% YTD and closed at all-time highs.
The Winners 📈
△ #15 S&P 500 – CBRE Group climbed 9.95% and earned the 15th spot on the ST Top 25 S&P 500 list as a Freshman.
$CBRE bested Q2 earnings expectations before the opening bell Thursday. The stock gapped up and gained 5% afterwards.
Here are the details:
EPS: $1.36 vs $0.78 est
REV: $6.4B, +20% YoY
Here’s the weekly chart:
$CBRE is up 53.8% YTD.
△ #17 N100 – Align Technologies debuted on the ST Top 25 N100 List in Week 30 thanks to a blistering 9% gain. The Invisalign maker is now ranked #17.
$ALGN ascended 8.86% and into new-highs on Thursday after the company reported record revenue of $1 billion for the first time. 🚀
EPS: $3.04 vs $2.45 est
REV: $1B, +187% YoY
Here’s the daily chart:
Align CEO Joe Hogan said:
“I’m pleased to report our first $1 billion revenue quarter with record volumes reflecting continued momentum from both Clear Aligners and Systems and Services. For Q2, Systems and Services revenues reflect strong growth and the strategic value of the iTero business in all regions with continued adoption of the iTero Element 5D Plus Series of next-generation scanners and imaging systems which launched in February.”
The company’s stock is now worth $695.80. Is $700 up next? Place your bets…
△ #18 R2K- PAVmed Inc popped into the party on the ST Top 25 R2K list this week. 🎊 The medical device company earned the #18 ranking as a Freshman.
$PAVM increased 12.3% on Wednesday after the company announced Stanley Lapidus, the founder and former CEO of Exact Sciences, has joined the board of directors of Lucid Diagnostics Inc., the company’s majority-owned subsidiary.
Lishan Aklog, PAVmed’s CEO and Lucid’s Executive Chairman commented:
“Stan has long been a leading figure in the medical diagnostics industry and is one of its most accomplished innovators in the early detection of cancer—innovations which have prevented countless deaths from cervical and colon cancer. Over the past year, Stan has made invaluable contributions as Lucid’s lead strategic advisor, including helping us craft several key strategic initiatives currently underway. I look forward to working with him even more closely in his new role as Vice Chairman, as Lucid seeks to execute on its long-term growth strategy.”
$PAVM is up 224% YTD and sits at three-year highs.
The Sinners 📉
▼ #2 R2K – Cassava Sciences sank 43.65% in Week 30 and gave away its #1 ranking on the ST Top 25 R2K List to AMC Entertainment.
On Thursday, $SAVA announced positive data on its investigational Alzheimer’s drug.
Simufilam significantly improved cognition in Alzheimer’s patients, with no safety issues. Simufilam improved cognition scores 3.0 points on ADAS-Cog11, an 18% mean improvement, baseline to month 9.
However, independent researchers have expressed doubts about the benefits of the drug. Those doubts sent the stock plunging 23.6% on Thursday and another 32.7% on Friday. Whoops…
Here’s the daily chart:
$SAVA is up 919.5% YTD.
▼ #9 N100 – eBay gave back all of Week 29’s gains and fell 4 spots from #5 to #9 on the ST Top 25 N100 List.
$EBAY opened ~2% lower Friday morning before finishing the day -7%. E-commerce stocks got dinged following Amazon’s worse-than-expected outlook for Q3.
$EBAY is still up 35.75% YTD.
See Y’all Next Week 🤙
